Coloplast A/S (OTCMKTS:CLPBY) Reaches New 12-Month Low – Here’s Why

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as $8.20 and last traded at $8.26, with a volume of 34265 shares. The stock had previously closed at $8.4250.

Wall Street Analyst Weigh In

Separately, Sanford C. Bernstein upgraded shares of Coloplast A/S to a “hold” rating in a research note on Wednesday, January 28th. Three investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company currently has an average rating of “Hold”.

Coloplast A/S Trading Down 0.8%

The firm has a fifty day simple moving average of $8.68 and a 200-day simple moving average of $9.10. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.61 and a quick ratio of 1.00. The firm has a market cap of $18.89 billion, a P/E ratio of 34.92, a price-to-earnings-growth ratio of 0.80 and a beta of 0.26.

Coloplast A/S (OTCMKTS:CLPBY) last released its quarterly earnings results on Tuesday, November 4th. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.02). Coloplast A/S had a net margin of 13.01% and a return on equity of 24.99%. The company had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.10 billion. On average, equities research analysts expect that Coloplast A/S Sponsored ADR will post 0.31 earnings per share for the current year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.